home / stock / fwbi / fwbi news

FWBI News and Press, First Wave BioPharma Inc. From 12/14/23

Stock Information
Company Name: First Wave BioPharma Inc.
Stock Symbol: FWBI
Market: NASDAQ
Menu
FWBI FWBI Quote FWBI Short FWBI News FWBI Articles FWBI Message Board
Get FWBI Alerts

News, Short Squeeze, Breakout and More Instantly...
FWBI - First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders

BOCA RATON, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma,” “First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic the...
FWBI - First Wave BioPharma to Participate in BIO Partnering @JPM During "J.P. Morgan Week 2024" 

BOCA RATON, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ...

FWBI - First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference

BOCA RATON, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
FWBI - Expected earnings - First Wave BioPharma Inc.

First Wave BioPharma Inc. (FWBI) is expected to report $-0.62 for Q3 2023

FWBI - First Wave BioPharma files for stock and warrants offering, size not disclosed

2023-11-03 17:21:26 ET More on First Wave BioPharma First Wave BioPharma CFO discloses sale of 1,676 shares First Wave Biopharma announces exercise of warrants, issuance of new warrants in private placement for $4M gross proceeds Seeking Alpha’s Quant Rating o...

FWBI - Date and Time Announced for First Wave BioPharma CEO James Sapirstein's Presentation at the 2023 BIO Investor Forum

BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...
FWBI - First Wave BioPharma CFO discloses sale of 1,676 shares

2023-10-09 10:34:19 ET More on First Wave BioPharma First Wave Biopharma announces exercise of warrants, issuance of new warrants in private placement for $4M gross proceeds Sanofi in licensing pact with First Wave BioPharma for GIT disorder drug Seeking Alpha’...

FWBI - First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference

BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointe...

FWBI - First Wave BioPharma files to sell 11.76M common shares for holders

2023-09-22 13:37:27 ET More on First Wave BioPharma Seeking Alpha’s Quant Rating on First Wave BioPharma Historical earnings data for First Wave BioPharma Financial information for First Wave BioPharma First Wave Biopharma announces exercise of warrant...
Previous 10 Next 10